Remote Cell Therapy Account Director - Mid-Atlantic

Pierre Fabre; United States; Remote; USD 170,000 - 250,000; Full time

Benefits offered by this job

Medical, dental, and vision coverage

401(k) plan

Generous PTO

Paid holidays

Parental leave

Employee discounts

Job summary

Pierre Fabre is launching a US division focused on rare diseases and oncology. We seek a highly motivated CTAD leader to drive the launch of Tab-cel, building a new US organization with a patient-centric approach and startup mindset.

In preapproval, lead disease awareness, expert relationships, and onboarding. Post-approval, drive demand, collaborations, and patient access across territories, coordinating across medical affairs, market access, and cell therapy operations.

Qualifications

• Bachelor’s degree required with strong scientific/medical acumen.
• At least 10 years in biopharma with cell therapy exposure.
• Proven ability to navigate a complex matrix and collaborate across functions.
• Experience communicating complex therapies to diverse stakeholders.
• Sales experience in ultra-rare diseases, CGT preferred.

Responsibilities

• Lead disease awareness efforts and relationships with clinical and non-clinical experts.
• Oversee onboarding for launching allogeneic cell therapy in target territories.
• Drive demand and support utilization and patient experience post-approval.
• Develop strategic account plans and cross-functional collaboration.
• Coordinate with marketing for US promotional materials and partnerships.

Skills

Cell Therapy expertise

Cross-functional collaboration

Biopharma sales experience

Scientific/clinical aptitude

Education

Bachelor's Degree

Job description

Pierre Fabre is launching a US division focused on rare diseases and oncology. We seek a highly motivated CTAD leader to drive the launch of Tab-cel, building a new US organization with a patient-centric approach and startup mindset.

In preapproval, lead disease awareness, expert relationships, and onboarding. Post-approval, drive demand, collaborations, and patient access across territories, coordinating across medical affairs, market access, and cell therapy operations.